Ambu A/S (OTCMKTS:AMBBY) Stock Price Down 5.1% - Here's What Happened

Key Points

• Ambu A/S stock price fell by 5.1%, trading at $15.04, with a significant increase in trading volume compared to the average.
• UBS Group has upgraded Ambu A/S to a "strong-buy" rating, contributing to an average rating of "Strong Buy" for the stock.
• The company's latest quarterly earnings revealed an EPS of $0.07 and revenue of $229.16 million, with a net margin of 5.93%.

Shares of Ambu A/S Unsponsored ADR (OTCMKTS:AMBBY - Get Free Report) fell 5.1% on Friday . The stock traded as low as $15.04 and last traded at $15.04. 633 shares changed hands during mid-day trading, an increase of 266% from the average session volume of 173 shares. The stock had previously closed at $15.85.

Wall Street Analysts Forecast Growth

Separately, UBS Group raised shares of Ambu A/S to a "strong-buy" rating in a research note on Tuesday, May 13th. One analyst has rated the stock with a Strong Buy rating, According to MarketBeat, the company currently has a consensus rating of "Strong Buy".

Ambu A/S Price Performance

The company has a debt-to-equity ratio of 0.08, a quick ratio of 1.67 and a current ratio of 2.88. The firm has a market cap of $3.53 billion, a PE ratio of 79.16 and a beta of 0.88. The stock has a fifty day moving average price of $15.13 and a 200-day moving average price of $16.19.

Ambu A/S (OTCMKTS:AMBBY - Get Free Report) last issued its earnings results on Friday, August 22nd. The company reported $0.07 earnings per share (EPS) for the quarter. Ambu A/S had a return on equity of 6.24% and a net margin of 5.93%.The business had revenue of $229.16 million during the quarter.

About Ambu A/S

Ambu A/S develops, produces, and sells medical devices to hospitals, clinics, and rescue services worldwide. The company offers anaesthesia, and patient monitoring and diagnostics products. The company also offers endoscopy products, such as bronchoscopes, rhinolaryngoscopes, duodenoscopes, cystoscopes, and display units; and neurology products, including EEG and EMG electrodes, EMG guided injections, and intraoperative monitoring products.